Pharmacological Definition of Antagonist
An antagonist is a drug that binds to a receptor but produces no intrinsic effect on its own, instead blocking the actions of agonists (activating ligands) and inverse agonists at that receptor. 1
Core Pharmacological Characteristics
Antagonists are defined by three key properties:
- Zero intrinsic activity – They occupy receptors without activating intracellular signaling pathways 2
- Competitive or allosteric binding – They bind to either the same site as the agonist (orthosteric) or a different site (allosteric) to prevent receptor activation 1
- Blockade of agonist responses – They inhibit responses stimulated by both endogenous and synthetic agonists 1, 2
The Spectrum of Receptor Activity
The classification of drugs exists on a continuum based on intrinsic activity 2:
- Full agonists – High intrinsic activity, produce maximal receptor activation 1
- Partial agonists – Intermediate intrinsic activity, cannot achieve full maximal response 1, 2
- Partial antagonists – Low intrinsic activity, minimal receptor activation 2
- Full antagonists – Zero intrinsic activity, no receptor activation 2
Important Nuances and Caveats
The distinction between antagonists and partial agonists becomes blurred depending on receptor constitutive activity 1:
- When a receptor has high constitutive (baseline) activity, an antagonist may behave functionally as a partial agonist 1
- Conversely, a partial agonist with very weak intrinsic activity may appear to function as an antagonist 1
- This context-dependency means that simple classification as "agonist" or "antagonist" can be misleading 1
Antagonists differ from inverse agonists, which actively suppress constitutive receptor activity below baseline levels, whereas pure antagonists simply prevent activation without reducing basal activity 3
Measurement and Validation
Proper characterization of antagonists requires rigorous methodology 4, 5:
- At minimum, two independent research groups should demonstrate reproducible receptor binding and functional blockade 4
- Schild analysis is the preferred method for determining antagonist equilibrium constants, superior to simple IC50 measurements 5
- Both radioligand binding and functional assays should ideally be employed in native tissues 4
Common pitfall: The term pA2 is frequently misused interchangeably with log KB (the negative logarithm of the antagonist dissociation constant), though they represent distinct measurements 6